- Record: found
- Abstract: found
- Article: found
Guide and Position of the International Society of Nutrigenetics/Nutrigenomics on Personalized Nutrition: Part 2 - Ethics, Challenges and Endeavors of Precision Nutrition
meeting-report
Author(s):
Martin Kohlmeier
a ,
Raffaele De Caterina
b ,
Lynnette R. Ferguson
c ,
Ulf Görman
d ,
Hooman Allayee
e ,
Chandan Prasad
f ,
Jing X. Kang
g ,
Carolina Ferreira Nicoletti
h ,
J. Alfredo Martinez
i, j
,
*
Publication date (Electronic):
11 June 2016
Journal:
Lifestyle Genomics
Publisher:
S. Karger AG
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Nutrigenetics considers the influence of individual genetic variation on differences in response to dietary components, nutrient requirements and predisposition to disease. Nutrigenomics involves the study of interactions between the genome and diet, including how nutrients affect the transcription and translation process plus subsequent proteomic and metabolomic changes, and also differences in response to dietary factors based on the individual genetic makeup. Personalized characteristics such as age, gender, physical activity, physiological state and social status, and special conditions such as pregnancy and risk of disease can inform dietary advice that more closely meets individual needs. Precision nutrition has a promising future in treating the individual according to their phenotype and genetic characteristics, aimed at both the treatment and prevention of disease. However, many aspects are still in progress and remain as challenges for the future of nutrition. The integration of the human genotype and microbiome needs to be better understood. Further advances in data interpretation tools are also necessary, so that information obtained through newer tests and technologies can be properly transferred to consumers. Indeed, precision nutrition will integrate genetic data with phenotypical, social, cultural and personal preferences and lifestyles matters to provide a more individual nutrition, but considering public health perspectives, where ethical, legal and policy aspects need to be defined and implemented.
Related collections
Most cited references112
- Record: found
- Abstract: found
- Article: not found
How does gene expression clustering work?
Patrik D'haeseleer (2005)
Clustering is often one of the first steps in gene expression analysis. How do clustering algorithms work, which ones should we use and what can we expect from them?
- Record: found
- Abstract: found
- Article: not found
Population History and Natural Selection Shape Patterns of Genetic Variation in 132 Genes
Joshua Akey, Michael A Eberle, Mark J. Rieder … (2004)
Introduction Despite intense study and interest, a detailed understanding of the evolutionary and demographic forces that have shaped extant patterns of human genomic variation remains elusive. An important goal in studies of DNA sequence variation is to identify loci that have been targets of natural selection and thus contribute to differences in fitness between individuals in a population. Identifying regions of the human genome that have been subject to natural selection will provide important insights into recent human history (Sabeti et al. 2002; Tishkoff and Verrelli 2003), the function of genes (Akey et al. 2002), and the mechanisms of evolutionary change (Otto 2000), and it may also facilitate the identification of complex disease genes (Jorde et al. 2001; Nielsen 2001). The neutral theory of molecular evolution (Kimura 1968; King and Jukes 1969), which posits that the majority of polymorphisms have no appreciable effects on fitness, has been integral to recent studies of natural selection. Specifically, the neutral theory makes explicit and quantitative predictions about the amount, structure, and patterns of sequence variation expected under neutrality, and serves as a null hypothesis by which to evaluate the evidence for or against selection in empirical data (Otto 2000; Nielsen 2001). Unfortunately, robust inferences of natural selection from DNA sequence data are difficult because of the confounding effects of population demographic history. For example, both positive selection and increases in population size lead to an excess of low-frequency alleles in a population relative to what is expected under a standard neutral model (i.e., a constant-size, randomly mating population at mutation-drift equilibrium). Therefore, rejection of the standard neutral model usually cannot be interpreted as unambiguous evidence for selection. One way out of this conundrum is to recognize that population demographic history affects patterns of variation at all loci in a genome in a similar manner, whereas natural selection acts upon specific loci (Cavalli-Sforza 1966; Przeworski et al. 2000; Andolfatto 2001; Nielsen 2001). Thus, by sampling a large number of unlinked loci throughout the genome, it is in principle possible to distinguish between selection and demography. For instance, Akey et al. (2002) recently used this approach to infer the presence of selection in a genome-wide collection of single nucleotide polymorphisms (SNPs). However, studies based on SNPs that were initially identified in a small sample and subsequently genotyped in a larger sample are not ideally suited for detecting selection, because ascertainment bias (i.e., a systematic bias introduced into a dataset because of the way in which the data were collected) complicates downstream analyses (Akey et al. 2003). However, DNA sequence data provides the opportunity to exhaustively catalog variation, which attenuates the problem of ascertainment bias and therefore is arguably the most powerful and direct approach for detecting selection. Here, we describe an extensive analysis of the molecular evolution of 132 genes that were comprehensively resequenced in 24 African-Americans and 23 European-Americans. In total, over 2.5 Mb of baseline reference DNA was sequenced, spanning 20 autosomal chromosomes and the X chromosome. The sampling of a large number of loci dispersed throughout the genome has allowed us to clarify the relative contributions of demography and selection to patterns of genetic variation at individual genes. Specifically, we developed a rigorous computational approach for taking into account multiple hypothesis tests and demographic history, and we found that while many apparent selective events can instead be explained by demography, there is also strong evidence for positive or balancing selection at eight genes in the European-derived population. In addition, we describe a striking example of a previously unreported recent selective sweep in European-Americans that spans four contiguous genes on Chromosome 7. More generally, our data provide insight into the demographic histories of African-American and European-American populations and have important implications for genetic association studies of complex diseases, as several of the genes showing evidence of selection have been implicated in susceptibility to complex human diseases. Results Statistical Tests Reveal Many Deviations from Neutrality We resequenced 132 genes primarily involved in inflammation, blood clotting, and blood pressure regulation and discovered a total of 12,890 SNPs (Table S1). We first characterized patterns of genetic variation by calculating several common summary statistics of the within-population allele frequency distribution, including Tajima's D, Fu and Li's D*, Fu and Li's F*, and Fay and Wu's H. As is conventionally done, we initially determined whether these statistics were significantly different from what is expected under a standard neutral model by performing coalescent simulations under the simplifying assumption of no recombination. In total, 28 genes in the European-American sample and ten genes in the African-American sample were nominally significant (i.e., the observed test statistic differed from neutral expectations at p < 0.05) in one or more tests of the allele frequency distribution (Figure 1). Thus, the European-American sample contained nearly three times as many significant genes as the African-American sample, and only three genes were significant in both samples (ABO, IL1RN, and TNFRSF1B). The direction of Tajima's D, Fu and Li's D*, and Fu and Li's F* is potentially informative about the evolutionary and demographic forces that a population has experienced. For example, negative values reflect an excess of rare polymorphisms in a population, which is consistent with either positive selection or an increase in population size. Positive values indicate an excess of intermediate-frequency alleles in a population and can result from either balancing selection or population bottlenecks. In the European-American sample, we observed eleven significantly positive and five significantly negative values for one or more of these three test statistics (Figure 1). In the African-American sample, we observed two significantly positive and five significantly negative values for one or more of the test statistics (Figure 1). The observations of both significantly positive and significantly negative values of Tajima's D, Fu and Li's D*, and Fu and Li's F*, combined with the largely nonoverlapping set of significant genes, could reflect selective pressures unique to one population (i.e., local adaptation), different demographic histories, spurious results, or most likely some complex combination of all of these factors. Although these results are intriguing, their interpretation is confounded by two issues: (1) We have not corrected for multiple hypothesis tests, and (2) rejection of the standard neutral model can result from either selective or demographic forces. In the subsequent sections, we develop approaches to address these issues with the dual goals of identifying genes that possess strong evidence of natural selection and of inferring population demographic history. Correcting for Multiple Hypothesis Tests In order to robustly correct for multiple hypothesis tests, the conventional practice of assuming no recombination when determining significance is not appropriate, because it results in conservative p values (Wall 1999) and hence decreases the statistical power to detect deviations from neutrality. Although recombination can easily be incorporated into coalescent simulations, in practice it is difficult to accurately estimate recombination rates, which vary substantially across the genome (Yu et al. 2001; McVean et al. 2004). To model the stochastic behavior and uncertainty in local rates of recombination, we reassessed the significance of Tajima's D, Fu and Li's D*, Fu and Li's F*, and Fay and Wu's H by coalescent simulations that incorporate recombination rates sampled from a Gamma(2, 0.5 × 10–8) distribution (see Materials and Methods). Finally, we corrected each statistic for multiple tests using the positive false discovery rate (FDR; Storey 2002) method, which determines the predicted proportion of “false positives” for the number of significant observations. In the European-American sample, we observed 22 genes that were significant at a FDR of 5% (i.e., we expect approximately one false positive in this set of genes) for one or more tests of the allele frequency distribution (Tables 1 and S2). Thus, the number of significant genes in the European-American sample, after incorporating recombination and correcting for multiple tests, is very similar to the initial results where recombination was ignored and multiple tests were not corrected for. However, in the African-American sample there were no genes significant at a FDR of 5% for any of the tests of the allele frequency distribution (unpublished data). This result is consistent with the relatively small number of significant genes that were initially found before correcting for multiple tests (Figure 1). Genes with the smallest FDR in African-Americans were ABO, F2RL1, and IL17B, which each had a FDR of 13.5% for Fu and Li's D*. Distinguishing between Selective and Demographic Forces Although neutrality tests of the allele frequency distribution reveal many significant deviations, it is impossible to unambiguously interpret these data as evidence for natural selection, because the null model used to assess significance makes unrealistic assumptions about population demographic history. In principle, it is possible to distinguish between demography and selection, because demography affects all loci in the genome, whereas selection acts upon specific loci. Thus, by sampling a large number of loci dispersed throughout the genome, we can begin to construct a more realistic null hypothesis by which to evaluate the evidence for or against selection (Kreitman 2000). To this end, we used the empirical data to explore four different demographic models (Figure 2A), which we could then use to account for demographic influences on tests of natural selection. For each model, we used coalescent theory to simulate data over a broad range of parameters and identified the particular combination of parameters that most closely matched summary statistics (average Tajima's D, Fu and Li's D*, and Fu and Li's F*) of the observed data. Of the four demographic models, the European-American data are most consistent with a bottleneck occurring approximately 40,000 y ago, which is nearly identical to a previously reported estimate (Sabeti et al. 2002). However, the confidence intervals for the observed summary statistics are broad, and various aspects of the data are also consistent with other models (Figure 2B). The African-American data are most consistent with either an exponential expansion or a relatively old and severe bottleneck (Figure 2). Similarly, using DNA sequence variation from ten unlinked, noncoding loci, Pluzhnikov et al. (2002) found that an African Hausa sample was consistent with a recent population expansion (although they did not consider bottleneck models). We reestimated the significance of Tajima's D, Fu and Li's D*, Fu and Li's F*, and Fay and Wu's H in each population for each of the four demographic models using the best-fit parameter values. All simulations included recombination and correction for multiple tests using the FDR method (with a FDR of 5%) as described above. Population history can clearly have a profound effect on tests of natural selection (Figure 3A and 3B; see also Simonsen 1995; Przeworski 2002), and given the uncertainty in our knowledge of human demographic history, it is challenging to ascribe unusual patterns of genetic variation to either demography or selection. To address this problem, we identified genes whose statistical evidence for selection was robust to demographic history. We conservatively defined demographically robust selection genes as those that demonstrated significant evidence for selection in all five demographic models. We identified eight demographically robust selection genes in European-Americans, and zero in African-Americans (Figure 3C; Table 2). Thus, out of the 22 genes originally found to be significant (at a FDR of 5%) under a standard neutral model, our estimates suggest that demographic history can potentially account for approximately two-thirds of these observations. Evidence for a Recent Selective Sweep on Chromosome 7q in European-Americans One particularly interesting region of the genome is located at 7q and contains four contiguous demographically robust selection genes (EPHB6, TRPV6, TRPV5, and KEL; Figure 4A). Collectively, the entire 115-kb region bears many of the hallmarks of a locus subject to a recent selective sweep: an excess of high-frequency-derived alleles (Figure 4B); an overall excess of rare polymorphisms, which results in an extreme skew of the site frequency spectrum reflected by sharply negative values of Tajima's D (Figure 4C); and a significant reduction in the amount of nucleotide diversity (Figure 4D). The signature of positive selection is seen only in European-Americans, suggesting that EPHB6, TRPV6, TRPV5, and/or KEL possess specific alleles that have conferred local adaptation to a unique environmental pressure in European-derived populations. Consistent with this hypothesis, we observed strong levels of population subdivision (Figure 4E) across the entire 115-kb region. The closest genes centromeric to EPHB6 and telomeric to KEL are approximately 42 kb and 64 kb away, respectively, suggesting that one or more of these four genes is the target of selection. However, we have not surveyed patterns of DNA sequence variation outside of the region delimited by EPHB6 and KEL, and therefore it is possible that the signature of selection extends even further. Based on the level of genetic variation on the putatively selected haplotype (see Materials and Methods), we can provide a rough estimate of the time back to the selective sweep as approximately 10,000 y ago. Although this number should be interpreted cautiously, it suggests that selection operated recently. Discussion In summary, we have found that both population demographic history and natural selection shaped patterns of DNA sequence variation in the 132 genes studied here. By studying multiple unlinked loci dispersed throughout the genome, we were able to develop a rigorous computational approach to distinguish between the confounding effects of natural selection and demographic history on patterns of genetic variation. Using this strategy, we found that approximately two-thirds of the genes that were initially significant could be accounted for by population demographic history. Thus, our analyses clearly demonstrate the importance of considering both neutral and nonneutral forces when interpreting DNA sequence variation. An interesting feature of our data is that the majority of deviations from neutrality, and all of the demographically robust selection genes, are not shared between the two population samples, suggesting that local adaptation has played an important role in recent human evolutionary history. Consistent with this observation, several possible examples of local adaptation in humans have previously been reported (Stephens et al. 1998; Rana et al. 1999; Hollox et al. 2001; Tishkoff et al. 2001; Currat et al. 2002; Fullerton et al. 2002; Gilad et al. 2002; Hamblin et al. 2002; Rockman et al. 2003). We hypothesize that the stronger signature of selection in the European-derived population may reflect the exposure of non-African populations to novel and evolutionarily recent selective pressures (e.g., unique dietary, climatic, and cultural environments) as modern humans migrated out of Africa and spread throughout the world. In contrast, the African-derived population may have experienced fewer evolutionarily recent selective forces. Theoretical studies have demonstrated that the power to detect a selective sweep is generally greatest if it occurred less than approximately 0.1 Ne generations ago (i.e., approximately 20,000–25,000 y ago [Kim and Stephan 2000; Przeworski 2002]), which is consistent with our hypothesis that signatures of selection in European-Americans reflect recent selective events. However, it is important to note that we have surveyed less than 1% of all human genes, and many of the genes that we did analyze are involved in mediating inflammatory and immune responses; thus our results may not be representative of the genome at large. Interestingly, Glinka et al. (2003) found that European-derived populations of Drosophila melanogaster demonstrated abundant evidence for recent selective sweeps, whereas African populations did not, which is strikingly similar to our results in humans. An alternative explanation for why we observed fewer significant results in African-Americans than in European-Americans is that African-Americans are an admixed population (Parra et al. 1998), and the admixture process may mask the signature of selection. However, simulation studies in which we constructed an artificially admixed European-American sample with African-American chromosomes resulted in an increase in significant genes relative to the observed data (unpublished data). Therefore, to the extent that our simulations recapitulate the dynamics of the admixture process in African-Americans, admixture is unlikely to explain the discrepancies between the two samples. It is important to point out that some genes that do not meet our rigorous definition of a high-confidence selection gene may have nonetheless been targets of selection, such as ABO in African-Americans (Table S2). In this initial survey we have elected to be conservative and identify genes that possess the strongest signatures of selection. Ultimately, it will be necessary to confirm our results in geographically diverse populations (a more comprehensive sampling of African populations is particularly needed), as well as in replicate samples of the populations we studied, and to functionally characterize the suspected targets of selection. Recently, Clark et al. (2003) presented an evolutionary analysis of 7,645 orthologous human-chimp-mouse gene trios by looking for accelerated rates of synonymous and nonsynonymous nucleotide substitution in either the human or the chimp lineages. In total, 50 genes overlap between our dataset and theirs (Table S3), including three demographically robust selection genes (TRPV6, EPHB6, and DCN; see Table 2). All three of the demographically robust selection genes also demonstrate statistically significant evidence (p < 0.05) of accelerated evolution in either the human (TRPV6 and EPHB6) or chimp (DCN) lineage. In addition, Clark et al. (2003) found evidence for accelerated evolution in seven genes along the human lineage that did not demonstrate evidence for selection in our dataset (Table S3). This observation may simply reflect either false negatives in our analysis or false positives in Clark et al. (2003). However, it is important to note that the statistical methods and data used to detect selection in Clark et al. (2003) (divergence between species) are quite different from our methods (polymorphism within species), so completely overlapping results are not expected. More specifically, the analyses of Clark et al. (2003) will preferentially detect selective events between species, whereas our analyses will preferentially identify selection operating within species. In other words, these two methods are complimentary and may potentially detect selection operating over different time scales. In this respect, it is particularly interesting that the genes we identified as possessing the strongest evidence for recent selection in one human population also show evidence of selection in the human or chimp lineage following their divergence (Clark et al. 2003). The strongest signature of selection that we observed occurs on Chromosome 7q in European-Americans. The signature of selection extends for at least 115 kb and spans the genes EPHB6, TRPV6, TRPV5, and KEL. To our knowledge, this is the largest footprint of selection that has been described in the human genome, and likely reflects the combination of strong and recent selective pressures and reduced recombination in this region (the average ratio of genetic to physical distance, cM/Mb, is approximately 0.68 according to the deCode map). Based on our current data it is impossible to identify which gene (or perhaps genes) has been the target (or targets) of selection. However, TRPV6 is a particularly interesting candidate, as it possesses three nonsynonymous amino acid substitutions (C157R, M378V, and M681T) that are each nearly fixed for the derived allele in European-Americans, show significant frequency differences between European-Americans and African-Americans, and are located in the most significant regions of both Tajima's D and reduced nucleotide diversity (Figure 4). The program PolyPhen (Ramensky et al. 2002) predicts that the C157R replacement may alter protein structure. Recently, TRPV6 was shown to be up-regulated in prostate cancer (Wissenbach et al. 2001), and a susceptibility locus for aggressive prostate cancer was mapped to the TRPV6 region (7q31–33; Paiss et al. 2003). These observations, combined with the large difference in disease prevalence between Europeans and African-Americans (Crawford 2003), make TRPV6 a strong candidate gene for prostate cancer susceptibility and/or aggressiveness. TRPV6, as well as TRPV5, constitute the rate-limiting step in kidney, intestine, and placenta calcium absorption (Nijenhuis et al 2003; van de Graaf et al. 2003). Interestingly, Northern European populations have very high frequencies of the lactase persistence allele (LCT*P; Hollox et al. 2001), which allows digestion of fresh milk throughout adulthood. It is widely accepted that strong selection has driven LCT*P to high frequency in Northern Europeans, beginning sometime after the domestication of animals approximately 9,000 y ago (Feldman and Cavalli-Sforza 1989; Hollox et al. 2001; Bersaglieri et al. 2004). What has been debated, however, is the specific selective advantage conferred by lactase persistence (Holden and Mace 1997). Our finding that TRPV6 and/or TRPV5 have been under strong selective pressure in Northern Europeans suggests that increased calcium absorption may have been the driving force behind selection for lactase persistence, which was originally hypothesized by Flatz and Rotthauwe (1973). Although additional studies are clearly needed, our results provide additional insight into the molecular mechanisms of adaptation to a new dietary niche (i.e., high-lactose diets). More generally, our results have several implications for mapping genes underlying complex human diseases. Specifically, four of the high-confidence selection genes have been implicated in various complex diseases (Table 3). If genes underlying complex diseases have experienced differential selective pressures, then this could in part explain the failure of many studies to replicate disease associations across populations (Florez et al. 2003; Moore 2003). Finally, our data are consistent with the notion that variation in genes that was once beneficial may have become detrimental in the environmental and cultural milieu of contemporary human populations, akin to the “thrifty gene” hypothesis for type II diabetes (Neel 1962). Materials and Methods DNA samples and sequencing Human DNAs were obtained from the Coriell Institute (Camden, New Jersey, United States). We analyzed DNA from 24 African-Americans from the Human Variation Panel, African-American Panel of 50 (HD50AA) and DNA from 23 European-Americans derived from various CEPH pedigrees. We also sequenced each gene in a common chimpanzee (Pan troglodytes) to determine the derived allele for Fay and Wu's H test. These data were generated under the auspices of the SeattleSNPs Program for Genomic Applications, which resequences candidate genes involved in inflammatory processes in humans. In general, we resequenced the complete genomic region for each gene, including introns and approximately 2 kb 5′ of the gene and 1 kb 3′ of the gene using Big-Dye terminator chemistry on an ABI 3700 or ABI 3730XL (Applied Biosystems, Foster City, California, United States). For several exceptionally large genes, such as F13A1, less than complete coverage was obtained (see Table S1). All variants occurring once in the sample were confirmed with an additional sequencing run. Further experimental details and all of the raw data can be found at our website (http://pga.gs.washington.edu/). Data analysis We calculated the following summary statistics of nucleotide variation for each gene: θ̂= S/an, where S is the number of segregating sites, and n is the sample size (Watterson 1975); , where hi is an unbiased estimate of nucleotide diversity for the ith segregating site (see equation 12 in Tajima 1989) and ηS , which is the number of singletons (Fu and Li 1993). From these statistics we calculated several tests of the standard neutral model including Tajima's D (Tajima 1989), Fu and Li's D* (Fu and Li 1993), Fu and Li's F* (Fu and Li 1993), and Fay and Wu's H statistic (Fay and Wu 2000). In calculating Fu and Li's F*, we used the formulas provided in Simonsen et al. (1995), which correct a typographical error in the original description of the method (Fu and Li 1993). For a discussion of the similarities and differences of Tajima's D, Fu and Li's D*, Fu and Li's F*, and Fay and Wu's H, see Fu and Li (1993), Simonsen et al. (1995), and Przeworski (2002). We initially assessed the significance of these statistics by comparing the observed values to 104 coalescent simulations (Hudson 1983), conditional on the observed sample size and number of segregating sites, assuming a standard neutral model with no recombination. Coalescent simulations were performed using the program ms (obtained from R. Hudson's Web site [http://home.uchicago.edu/~rhudson1/source.html]). In order to correct for multiple tests, we repeated the coalescent simulations as described above, but included recombination. Following Pluzhnikov et al. (2002), for each of the 104 coalescent realizations, we sampled the recombination rate from a Gamma(2, 0.5 × 10–8) distribution whose expectation equals the average genome-wide recombination rate of 10–8/generation (Hamblin et al. 2002). The positive FDR method was used to correct for multiple hypothesis tests using the software QVALUE (Storey 2002; http://faculty.washington.edu/~jstorey/qvalue/). We quantified the allele frequency differences between the European- and African-American samples by the statistic FST as described in Akey et al. (2002). All of the analyses described above excluded insertion/deletion polymorphisms, but their inclusion does not affect any of our conclusions (unpublished data). We assigned PANTHER Biological Process terms (Thomas et al. 2003) to each gene. We estimated the time since the selective sweep for the Chromosome 7q region in European-Americans by analyzing the amount of nucleotide diversity that has accumulated on the selected haplotype as described in Rozas et al. (2001). We assumed that TRPV6 is the target of selection and the selected haplotype is defined by the C157R, M378V, and M681T polymorphisms. If mutations are Poisson-distributed, the expected number of segregating sites in a genealogy is E[S] = μE[T], where S, μ, and T denote segregating sites, neutral mutation rate of the locus, and total branch length of the genealogy, respectively. Assuming a star-shaped genealogy, E[T] = n × t, where n is the number of selected haplotypes. Thus, the time back to the selective sweep, t, can be estimated by S/(nμ). For TRPV6 in European-Americans, n = 45 (i.e., 45 out of 46 haplotypes carry C157, M378, and M681), S = 11, and μ = 2.5 × 10–5. Demographic modeling We assessed the impact of demographic history on the robustness of the statistical tests of neutrality by using coalescent theory to simulate data under four different population histories, including a bottleneck, exponential expansion, population structure according to an island model that allows symmetric migration between demes, and population structure assuming population splitting with no subsequent migration. For each model we simulated data under a wide variety of parameters by conditioning on the observed sample size and θ̂W for each population. The bottleneck model is specified by the parameters F (the inbreeding coefficient) and t (the time in years measured from the present) at which the bottleneck occurred. Values of F and t considered were F = [0.05, 0.075, … , 0.40] and t = [10,000, 20,000, … , 100,000]. The exponential expansion model is determined by the parameters α (the growth rate/generation) and t (the time, in years measured from the present, at which the population began increasing in size). Values considered for α and t were: α = [0.0005, 0.001, … , 0.01] and t = [10,000, 20,000, … , 100,000]. The population structure under an island model is specified by the population migration rate between demes, M = 4Nom, where No and m are the effective subpopulation size and fraction of migrants in each subpopulation per generation, respectively. Values of M considered were M = [1, 2, … , 10]. The structure model assuming population splitting with no subsequent migration is determined by the parameter t (the time in years since the populations diverged). Values of t considered were t = [1,000, 2,000, …, 10,000]. In all simulations we assumed an effective population size of 10,000 and a generation time of 25 y in order to facilitate comparisons to a previous study (Sabeti et al. 2002). The parameter space for each model included a full grid search, so we tested 160, 100, 10, and 10 parameter combinations for the bottleneck, expansion, structure (island), and structure (splitting) models, respectively. We performed 104 simulations for each parameter combination. For each demographic model, we calculated the average value of Tajima's D, Fu and Li's D*, and Fu and Li's F* and compared the results to the observed values of these statistics. For the bottleneck and exponential expansion models, we identified the parameter values that most closely matched the observed data by identifying the parameter combination that minimized the function , where TOi and TSi denote the observed and simulated averages of Tajima's D, Fu and Li's D*, and Fu and Li's F*. For the demographic models of population structure we selected parameter values that matched the observed FST. Finally, we reassessed the significance of the observed values of Tajima's D, Fu and Li's D*, Fu and Li's F*, and Fay and Wu's H by 104 coalescent simulations for each demographic model using the best-fit parameter values. Supporting Information Table S1 Summary Statistics of the 132 Genes (266 KB DOC). Click here for additional data file. Table S2 Neutrality Test Statistics (534 KB DOC). Click here for additional data file. Table S3 Overlap of Genes Analyzed by Clark et al. (2003) (87 KB DOC). Click here for additional data file. Accession Numbers LocusLink ID numbers (http://www.ncbi.nlm.nih.gov/LocusLink/) for the genes discussed in this paper are ABO (28), ACE2 (59272), APOH (350), BDKRB2 (624), BF (629), C2 (717), CCR2 (1231), CD36 (948), CEBPB (1051), CRF (10882), CRP (1401), CSF2 (1437), CSF3 (1440), CSF3R (1441), CYP4A11 (1579), CYP4F2 (8529), DCN (1634), EPHB6 (2051), F10 (2159), F11 (2160), F12 (2161), F13A1 (2162), F2 (2147), F2R (2149), F2RL1 (2150), F2RL2 (2151), F2RL3 (9002), F3 (2152), F5 (2153), F7 (2155), F9 (2158), FGA (2243), FGB (2244), FGG (2266), FGL2 (10875), FSBP (10646), GP1BA (2811), ICAM1 (3383), IFNG (3458), IGF2 (3481), IGF2AS (51214), IL10 (3586), IL10RA (3587), IL10RB (3588), IL11 (3589), IL12A (3592), IL12B (3593), IL13 (3596), IL15RA (3601), IL17B (27190), IL19 (29949), IL1A (3552), IL1B (3553), IL1R1 (3554), IL1R2 (7850), IL1RN (3557), IL2 (3558), IL20 (50604), IL21R (50615), IL22 (50616), IL24 (11009), IL2RB (3560), IL3 (3562), IL4 (3565), IL4R (3566), IL5 (3567), IL6 (3569), IL8 (3576), IL9 (3578), IL9R (3581), IRAK4 (51135), ITGA2 (3673), ITGA8 (8516), JAK3 (3718), KEL (3792), KLK1 (3816), KLKB1 (3818), KNG (3827), LTA (4049), LTB (4050), MAP3K8 (1326), MC1R (4157), MMP3 (4314), MMP9 (4318), NOS3 (4846), PFC (5199), PLAT (5327), PLAU (5328), PLAUR (5329), PLG (5340), PON1 (5444), PON2 (5445), PPARA (5465), PPARG (5468), PROC (5624), PROCR (10544), PROS1 (5627), PROZ (8858), PTGS2 (5743), SCYA2 (6347), SELE (6401), SELL (6402), SELP (6403), SELPLG (6404), SERPINA5 (5104), SERPINC1 (462), SERPINE1 (5054), SFTPA1 (6435), SFTPA2 (6436), SFTPB (6439), SFTPC (6440), SFTPD (6441), SMP1 (23585), STAT4 (6775), STAT6 (6778), TF (7018), TFPI (7035), TGFB3 (7043), THBD (7056), TIRAP (114609), TNF (7124), TNFAIP1 (7126), TNFAIP2 (7127), TNFAIP3 (7126), TNFRSF1A (7132), TNFRSF1B (7133), TRAF6 (7189), TRPV5 (56302), TRPV6 (55503), VCAM1 (7412), VEGF (7422), and VTN (7448). Coriell (http://coriell.undmj.edu/) repository numbers for human genomic DNAs sequenced for this study are as follows. DNAs from African-Americans were NA17101–NA17116 and NA17133–NA17140. DNAs from European-Americans were NA06990, NA07019, NA07348, NA07349, NA10830, NA10831, NA10842–NA10845, NA10848, NA10850–NA10854, NA10857, NA10858, NA10860, NA10861, NA12547, NA12548, and NA12560.
- Record: found
- Abstract: found
- Article: not found
The Use of Mobile Devices in Aiding Dietary Assessment and Evaluation.
Vivian Zhu, Edward Delp, Antje D. Ebert … (2010)
There is a growing concern about chronic diseases and other health problems related to diet including obesity and cancer. The need to accurately measure diet (what foods a person consumes) becomes imperative. Dietary intake provides valuable insights for mounting intervention programs for prevention of chronic diseases. Measuring accurate dietary intake is considered to be an open research problem in the nutrition and health fields. In this paper, we describe a novel mobile telephone food record that will provide an accurate account of daily food and nutrient intake. Our approach includes the use of image analysis tools for identification and quantification of food that is consumed at a meal. Images obtained before and after foods are eaten are used to estimate the amount and type of food consumed. The mobile device provides a unique vehicle for collecting dietary information that reduces the burden on respondents that are obtained using more classical approaches for dietary assessment. We describe our approach to image analysis that includes the segmentation of food items, features used to identify foods, a method for automatic portion estimation, and our overall system architecture for collecting the food intake information.
Author and article information
Journal
Journal ID (publisher-id): JNN
Journal ID (nlm-ta): Lifestyle Genomics
Journal ID (doi): 10.1159/issn.2504-3188
Title:
Lifestyle Genomics
Publisher:
S. Karger AG
ISSN
(Print):
2504-3161
ISSN
(Electronic):
2504-3188
Publication date Subscription-year: 2016
Publication date
(Print):
June
2016
Publication date
(Electronic):
11
June
2016
Volume: 9
Issue: 1
Pages: 28-46
Affiliations
aDepartment of Nutrition, School of Public Health, School of Medicine, University of
North Carolina at Chapel Hill, Chapel Hill, N.C., USA;
bInstitute of Cardiology ‘G. d'Annunzio' University and Center of Excellence on Aging,
Chieti, Italy;
cDiscipline of Nutrition, and Auckland Cancer Society Research Centre, FM & HS,
University of Auckland, and Nutrigenomics New Zealand, University of Auckland, Auckland,
New Zealand;
dEthics Unit, Centre for Theology and Religious Studies, Lund University, Lund, Sweden;
eDepartment of Preventive Medicine, USC Keck School of Medicine, Los Angeles, Calif.,
fDepartment of Nutrition and Food Sciences, Texas Woman's University, Denton, Tex.,
and
gLaboratory for Lipid Medicine and Technology, Department of Medicine, Massachusetts
General Hospital and Harvard Medical School, Boston, Mass., USA;
hDepartment of Internal Medicine, Faculty of Medicine of Ribeirão Preto, University
of São Paulo, Ribeirão Preto, Brazil;
iDepartment of Nutrition, Food Science and Physiology, and Center for Nutrition Research,
University of Navarra, and Navarra Institute for Health Research (IdiSNA), Pamplona,
jCIBERobn, Physiopathology of Obesity, Carlos III Institute, Madrid, Spain
Author notes
Article
Publisher ID: 446347 Other ID: J Nutrigenet Nutrigenomics 2016;9:28-46DOI: 10.1159/000446347
PubMed ID: 27286972
SO-VID: 95830cd1-34d0-4243-8fe9-35f54764c1fb
Copyright © © 2016 S. Karger AG, Basel
License:
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
History
Page count
Figures: 2,
References: 159,
Pages: 19
Categories
Subject:
10th Congress of the International Society of Nutrigenetics/Nutrigenomics
Data availability: